Related Experiment Video
Updated: Aug 6, 2025
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.1K
Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type
Christopher B Sylvester1, Christopher T Ryan2, William C Frankel3
1Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas; Department of Bioengineering, Rice University, Houston, Texas.
The Journal of Surgical Research
|March 18, 2023
Summary
Bioprosthetic aortic valve replacement (B-AVR) shows similar early outcomes to mechanical AVR (M-AVR) but with fewer readmissions. Bleeding and coagulopathy drive M-AVR readmissions, suggesting improved anticoagulation management is key.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Health Outcomes Research
Background:
- Choice between mechanical (M-AVR) and bioprosthetic (B-AVR) aortic valves involves trade-offs: lifelong anticoagulation vs. structural degeneration.
- Understanding long-term outcomes and readmission rates is crucial for optimal prosthesis selection.
Purpose of the Study:
- To compare the risk-adjusted outcomes and readmission rates between mechanical and bioprosthetic aortic valve replacement.
- To identify key drivers of readmission in patients undergoing aortic valve replacement.
Main Methods:
- Analysis of the Nationwide Readmissions Database for isolated surgical AVR between 2016-2018.
- Propensity score matching to compare outcomes between B-AVR and M-AVR groups.
- Kaplan-Meier analysis to estimate 1-year readmission rates.
Main Results:
- After propensity score matching, B-AVR patients had similar in-hospital mortality and costs compared to M-AVR patients.
- B-AVR patients experienced shorter length of stay and significantly lower readmission rates at 30 days, 90 days, and 1 year.
- Readmissions for bleeding, coagulopathy, and effusions were significantly lower in the B-AVR group.
Conclusions:
- Bioprosthetic aortic valve replacement offers comparable early outcomes to mechanical AVR with reduced readmission rates.
- Bleeding, coagulopathy, and effusions are significant contributors to readmissions in M-AVR patients.
- Strategies to reduce bleeding and optimize anticoagulation management are essential for improving outcomes in the first year post-AVR.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
30
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
30
01:23Peripheral Artery Disease V: Postoperative Nursing Management
15
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
15
01:15Aortic Regurgitation I: Introduction
21
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
21
01:26Aneurysm III: Interprofessional Care
15
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
15
01:22Aneurysm IV: Nursing Management
13
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
13
01:17Aortic Regurgitation IV: Nursing Management
34
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
34